| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_634715a790f7ef0163a61e9f364bebcd |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4422 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4422 |
| filingDate |
1996-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2000-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3af28aedf343bbb505c4342c1b71df6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d24377e95511b5dcdc0aa12c6b777631
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_327006fa786c19354deea12c86c78108
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cdeab5669a65615cc8c2e2d40eaea0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17a53ecf1130b8cc03e78296fe3dd001 |
| publicationDate |
2000-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-396038-B |
| titleOfInvention |
Pharmaceutical composition comprising felodipine for treating cerebral dysfunction due to solvent exposure |
| abstract |
Use of 2,6-dimethyl-4-(2,3-dichlorophenyl-1,4-dihydropyridine-3,5-dicarboxylic acid-3-methyl-5-ethyl ester or a pharmaceutically acceptable salt thereof for the manufacture of a pharmaceutical preparation for the treatment of cerebral dysfunction due to solvent exposure. |
| priorityDate |
1995-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |